Daehan New Pharm Minoxidil Tablets (Minoxidil)
Minoxidil 5mg
Tablet · Prescription medication
Daehan New Pharm Co., Ltd.
MFDS item code 202104812 · Notified 2021.06.23
This product's status changed to Approval withdrawn on 2024.01.03. It may no longer be sold, so consult a doctor or pharmacist before taking it.
Treatment of hypertension (resistant, symptomatic, or with target-organ damage)
This medication is used for the treatment of hypertension caused by secondary conditions or target organ damage. It is also effective in resistant hypertension that does not respond even when combined with diuretics and two types of antihypertensive agents. It helps improve these hypertensive states and aids in blood pressure control.
Adults (12 years and older): Administer an initial dose of 5㎎ of minoxidil orally once daily, and a maintenance dose of 10-40㎎ per day in 1 or more divided doses. A maximum of 100㎎ per day may be administered. Frequency of administration: During treatment with this medicine, the magnitude of fluctuations in arterial blood pressure over the course of a day is proportional to the reduction in blood pressure. If the reduction in supine diastolic blood pressure is less than 30mmHg, once-daily administration may be used; if it is 30mmHg or more, administer the daily dose in 2 divided doses. Dose changes: Determine the dose carefully according to the patient's response. When adjusting the dose, allow an interval of at least 3 days, as an adequate response to a dose may take 3 days or more to appear. If more rapid treatment of hypertension is required, the dose may be adjusted every 6 hours while the patient is carefully monitored. Concomitant administration Diuretics: This medicine is administered with a diuretic in patients who rely on renal function to maintain salt and water balance. It has been administered concomitantly with the following diuretics: ① Hydrochlorothiazide (50㎎ per dose, twice daily) or another thiazide diuretic (equivalent effective dose) ② Chlorthalidone (50-100㎎ per dose, once daily) ③ Furosemide (40㎎ per dose, twice daily) If excessive salt and water retention results in a weight gain of approximately 1.8㎏ or more, the diuretic should be changed to furosemide. If the patient is already receiving furosemide, increase the dose as needed. β-blockers or other sympatholytic agents: During treatment with this medicine, administer a β-blocker in divided doses equivalent to 80-160㎎ of propranolol per day. If β-blockers are contraindicated, methyldopa (250-750㎎ per dose, twice daily) may be administered instead. Since methyldopa takes time to exert its effect, administer it at least 24 hours before starting this medicine. Sympatholytic agents may not completely block the increase in heart rate caused by this medicine, but they can generally prevent tachycardia. Patients who were receiving a β-blocker before starting therapy with this medicine typically have bradycardia; however, their heart rate is expected to increase to normal after this medicine is administered. When this medicine is administered concomitantly with a β-blocker or another sympatholytic agent, their opposing effects on the heart largely counterbalance each other, resulting in little change in heart rate. Adjust the dose appropriately according to age and symptoms.
Children (12 years and under): Administer an initial dose of 0.2㎎ per ㎏ of body weight once daily. The dose may be increased by 50-100% until blood pressure is optimally controlled. The maintenance dose is 0.25㎎-1.0㎎ per ㎏ of body weight per day. A maximum of 50㎎ per day may be administered.
This medication should not be used in patients with certain conditions. For example, patients with pheochromocytoma should not be administered this medication because it can lower blood pressure while stimulating the secretion of specific hormones from the tumor. Patients with pulmonary hypertension due to mitral stenosis, patients with acute myocardial infarction, and patients who have had an allergic reaction to this medication should also avoid it. Caution should be exercised when administering this medication to patients with chronic congestive heart failure, severe renal failure, and angina pectoris, and their condition should be monitored closely according to the physician's instructions. When taking this medication, excessive hair growth or thickening may occur, primarily appearing on the face and body, which will gradually return to normal upon discontinuation of the medication. Skin rashes or allergic reactions may also occur, so care is necessary. Blood tests may show a decrease in platelet or white blood cell counts, and liver function tests may change. Changes in cardiac electrical signals may be observed in electrocardiogram tests; however, most recover with continued treatment and do not cause significant issues with heart function. Rarely, pericardial effusion can occur, especially in patients with poor kidney function, who need to exercise even more caution and may require further examinations if symptoms arise. During treatment with this medication, fluid retention leading to edema may occur, so it is usually used in combination with diuretics to manage fluid balance. Since the medication causes vasodilation, heart rate may increase; thus, it is often taken with other medications to prevent this symptom. Patients with reduced kidney function or those on dialysis should have their dosage adjusted, and it should only be used in stable status after myocardial infarction. Regular examinations, including urinalysis, kidney function tests, electrocardiograms, and chest X-rays, are necessary at the start of the treatment. This medication can interact with other drugs, so caution is needed, especially when taken with antihypertensive medications, antidepressants, or non-steroidal anti-inflammatory drugs. Safety during pregnancy has not been established, and it is recommended to avoid use during breastfeeding or to stop nursing if necessary. Experience with this drug in children, particularly neonates, is limited, and it should be administered carefully. In the event of overdose, hypotension may worsen, so immediate medical attention is required to receive appropriate treatment, and certain medications or saline solutions can be used to control blood pressure.
Hair growth, thickening, pigmentation increase, exudative rash, vesicular lesions, mucosal syndrome, thrombocytopenia, leukopenia, decreased hematocrit, decreased hemoglobin, decreased erythrocytes, increased ALP, changes in direction and amplitude of ECG T-wave, pericardial effusion, ischemia, peripheral edema, increased heart rate, elevated creatinine, elevated BUN, gastrointestinal disturbances, rash, mastalgia, gynecomastia, hemolytic anemia, pulmonary infiltration, increased antinuclear antibodies, headache, intermittent claudication, frequent menstruation, nausea, vomiting
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly sealed container to protect it from air and moisture, ideally at room temperature between 1 to 30 degrees Celsius. Proper storage helps maintain the efficacy of the medication and prevents degradation.
White round tablets
30 tablets/bottle, 100 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Minoxidil 5mg
Tablet · Prescription medication
Daehan New Pharm Co., Ltd.

Minoxidil 5mg
Tablet · Prescription medication
Hyundai Pharmaceutical Co., Ltd.
Minoxidil 3g
OTC medication
Hyundai Pharmaceutical Co., Ltd.
Minoxidil 5g
OTC medication
Hyundai Pharmaceutical Co., Ltd.
Minoxidil 5g
OTC medication
Hanmi Pharmaceutical Co., Ltd.
Minoxidil 5g
Solution · OTC medication
JW Pharmaceutical Corp.
Minoxidil 3g
Solution · OTC medication
Haitai HTB Co., Ltd.
Minoxidil 5g
Solution · OTC medication
Ilhwa Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.